Kirby Daniel Gordon 4

4 · IOVANCE BIOTHERAPEUTICS, INC. · Filed Feb 26, 2026

AI-generated summary of this filing

Updated Feb 26, 2026

IOVANCE (IOVA) CCO Daniel Gordon Receives 120,000 Shares (PSU Vest)

What Happened

Daniel Gordon, Chief Commercial Officer of Iovance Biotherapeutics (IOVA), had performance-based restricted stock units (PSUs) vest on February 24, 2026. 120,000 shares were issued upon vesting (acquired at $0.00), and 34,165 of those shares were withheld by the company to satisfy mandatory tax withholding (withheld shares valued at $3.78 each, totaling $129,144). After withholding, 85,835 shares remained issued to him from this vesting event.
The original award was for up to 150,000 PSUs; 120,000 vested and 30,000 were canceled per the award terms.

Key Details

Transaction date: February 24, 2026; Form 4 filed February 26, 2026.
Vested/issued: 120,000 shares acquired at $0.00 (PSU conversion).
Tax withholding: 34,165 shares withheld at $3.78/share = $129,144 (this is not an open-market sale).
Shares remaining from this vesting after withholding: 85,835.
Award background: 150,000 PSUs granted on Feb 10, 2025; vesting occurred based on financial milestones (120k vested, 30k canceled).
No indication in the filing of a late report.

Context

PSUs are compensation awards that convert to company stock only if performance conditions are met; each PSU equals a contingent right to one share. This was an employer-administered vesting event, not a purchase or open-market sale by the insider.
Withholding to cover taxes is routine and should not be interpreted as a sign of trading sentiment.

Form 4

Period: 2026-02-24

Chief Commercial Officer

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-02-24+120,000→ 173,546 total
Tax Payment
Common Stock
[F2][F3]
2026-02-24$3.78/sh−34,165$129,144→ 139,381 total
Exercise/Conversion
Restricted Stock Units
[F4][F5]
2026-02-24−150,000→ 0 total
→ Common Stock (150,000 underlying)

Footnotes (5)

[F1]Represents the number of shares of the Issuer's common stock underlying performance-based restricted stock units ("PSUs") that have been earned based on the level of achievement of certain financial milestones. The earned PSUs vested on February 24, 2026.
[F2]Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the PSUs. This is not an open market sale of securities.
[F3]Represents the common stock remaining after deducting the common stock withheld for taxes.
[F4]Each PSU represents a contingent right to receive one share of the Issuer's common stock.
[F5]On February 10, 2025, the Reporting Person was granted an award of up to 150,000 PSUs, which vests in the form of shares of the Issuer's common stock upon the achievement of certain financial milestones. On February 24, 2026, certain financial milestones were met, resulting in the vesting of the PSUs as to 120,000 of the underlying shares and the cancellation of the PSUs as to 30,000 of the underlying shares.

Signature

/s/ Daniel Gordon Kirby|2026-02-26

1 file